Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05112289 · ClinicalTrials.gov registry record · NA

A Study to Evaluate White Matter Hyperintensities in Migraine

A NA study of Multiple Sclerosis and Migraine, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05112289 is a NA study of Multiple Sclerosis and Migraine that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05112289, a NA study of Multiple Sclerosis and Migraine, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines

Interventions

  • DIAGNOSTIC_TEST Brain Neuroimaging

Study Locations (1)

Arizona

  • Mayo Clinic in Arizona - Phoenix

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-08-16
Est. Completion 2026-08
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05112289

The ClinicalTrials.gov registry entry for NCT05112289 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Brain Neuroimaging is the first listed.

NCT05112289 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05112289 about?

NCT05112289 is a clinical study titled "A Study to Evaluate White Matter Hyperintensities in Migraine". The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines

What is the current status of trial NCT05112289?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-08-16. Estimated completion is 2026-08.

What conditions does trial NCT05112289 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Migraine, Small Vessel Ischemic Disease.

What interventions are being tested in trial NCT05112289?

The interventions under investigation include: Brain Neuroimaging (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05112289?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05112289 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.